Five things for pharma marketers to know: Wednesday, December 13, 2017

Teva diminishes debt with job cuts and sale; FDA to study whether consumers can detect misleading ads; AbbVie, Roche present positive Phase-III data at ASH

Experts weigh in: How will health technology advance in 2018?

Innovation-minded executives share their thoughts and predictions for the year ahead.

Amarin's Salyer preps for Vascepa push

Amarin's Salyer preps for Vascepa push

Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."

Infographic | HCPs must deal with communication breakdown

Infographic | HCPs must deal with communication breakdown

Drugmakers are proud of the patient service programs they've developed. Yet there remains a disconnect in the way information is communicated to HCPs.

How will the pharma industry fare in 2018 under Trump?

How will the pharma industry fare in 2018 under Trump?

The first year of the Trump administration was kind to pharma, but it might not be so fortunate in 2018.

Open Lens

Drugmakers have access to an abundance of data, but do they know how to use it to better communicate their stories and key messages? Michael Joachim, SVP, Growth and Innovation at Medicx, shares his insights with Larry Dobrow, MM&M senior editor.

Ironwood strengthens leadership with two new hires

Ironwood strengthens leadership with two new hires

The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.

Rejuvenan Global Health names Hudson Cutler communications AOR

Rejuvenan Global Health names Hudson Cutler communications AOR

The digital health startup was founded in 2015.

Five things for pharma marketers to know: Tuesday, December 12, 2017

Five things for pharma marketers to know: Tuesday, December 12, 2017

FDA issues prescription drug promotion guidance; FDA approves first follow-on biologic of Lilly's Humalog; drugmakers allegedly hired nurses to promote drugs

GCI Health confirms Jones and Kerry as joint MDs of London operation

GCI Health confirms Jones and Kerry as joint MDs of London operation

GCI Health has confirmed new hire Kath Kerry and maternity leave returner Rikki Jones as co-MDs of its London operation, the network's second hub alongside its New York headquarters.

Five things for pharma marketers to know: Monday, December 11, 2017

Five things for pharma marketers to know: Monday, December 11, 2017

Pfizer's Viagra generic to sell for half the price; GSK seeks oncology deals; Ionis' experimental Huntington's drug tackles toxic protein for the first time

TAG-certified channels have 83% fewer incidences of ad fraud

TAG-certified channels have 83% fewer incidences of ad fraud

A study has found that channels certified by the Trustworth Accountability Group (TAG) had 83% less ad fraud than the broader industry average.

Terry Savage to leave Cannes Lions after 33 years

Terry Savage to leave Cannes Lions after 33 years

Cannes Lions' longtime leader, chief spokesman, and a figure many viewed as the heart and soul of the global creativity festival, will be moving on after the 2018 event ends.

Five things for pharma marketers to know: Friday, December 8, 2017

Five things for pharma marketers to know: Friday, December 8, 2017

FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance

Five things for pharma marketers to know: Thursday, December 7, 2017

Five things for pharma marketers to know: Thursday, December 7, 2017

UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval

GCI Health puts Edie DeVine in charge of medical, health tech

GCI Health puts Edie DeVine in charge of medical, health tech

DeVine will oversee the agency's health IT and medical device work.

Lighthouse wins grand prize for voice-activated diabetes app at Hitlab

Lighthouse wins grand prize for voice-activated diabetes app at Hitlab

Lighthouse received $50,000 for application aimed at providing more accessible and engaging care for those living with diabetes.

What happens as marketers shift from algorithms to AI and other 2018 predictions

What happens as marketers shift from algorithms to AI and other 2018 predictions

Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.

Five things for pharma marketers to know: Wednesday, December 6, 2017

Five things for pharma marketers to know: Wednesday, December 6, 2017

FDA approves Novo's diabetes drug; Walgreens undergoes rebranding in the wake of CVS-Aetna merger; pharma increasingly transparent about clinical trial data

Five things for pharma marketers to know: Tuesday, December 5, 2017

Five things for pharma marketers to know: Tuesday, December 5, 2017

Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds

GroupM unveils upbeat global adspend forecast for 2018

GroupM unveils upbeat global adspend forecast for 2018

GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.